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Increased Arterial Wave
Reflection Magnitude
A Novel Form of
Stage B Heart Failure?*
Sanjiv J. Shah, MD, J. Andrew Wasserstrom, PHD
hicago, Illinois
Heart failure (HF) is a major public health problem: it
affects 6 million people in the United States (1), the
lifetime risk for developing HF after the age of 40 years is
20% (2), and 5-year survival after HF hospitalization is a
dismal 35%, regardless of underlying left ventricular (LV)
ejection fraction (EF) (3). These statistics highlight the
urgent need for prevention of HF and better understanding
of how and why HF develops in high-risk individuals, such
as those with systemic hypertension. During the transition
from risk factors (e.g., hypertension) to symptomatic HF,
abnormalities in cardiac structure and function (e.g., LV
hypertrophy, LV diastolic and/or systolic dysfunction, and
abnormal cardiac mechanics [4]) can occur and represent an
asymptomatic form of “subclinical” (Stage B) HF. The
importance of Stage B HF cannot be underestimated—
once symptomatic (Stage C) HF develops, treatment is
See page 2170
costly, morbidity is high, and in a large and increasingly
prevalent proportion of HF (those with preserved EF [3,5]),
treatment options are limited (6). Thus, curbing the HF
epidemic will require the identification and treatment of
high-risk Stage B patients, with the goal of preventing
progression to symptomatic HF.
In studies of HF development, the LV is often considered
in isolation, even though the maladaptive interaction be-
tween the systemic arteries and the LV (7) contributes to
cardiomyocyte malfunction, abnormal cardiac mechanics,
and ultimately, HF. In line with the LV-centric focus,
current guidelines and studies on Stage B HF have focused
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paper to disclose.on LV abnormalities (e.g., LV hypertrophy, reduced LVEF,
LV diastolic dysfunction, and history of myocardial infarc-
tion) (8,9). Should we expand the definition of Stage B HF
to include arterial properties known to have deleterious
effects on the LV? Here, the line between Stage A HF (e.g.,
hypertension) and Stage B HF (abnormal LV structure/
function) is blurred. A clear demonstration of the associa-
tion between abnormal central aortic pressure waveform
characteristics and incident HF has been the missing
link—a critical unmet need—to verify the importance of
abnormal central aortic wave reflections in the pathogenesis
of HF.
In this issue of the Journal, Chirinos et al. (10) report
heir results from an investigation of the association of
entral aortic pressure profiles and incident cardiovascular
vents (including HF) in MESA (Multi-Ethnic Study of
therosclerosis). The authors used validated methods for
etermining central pressure phenotypes (augmentation in-
ex, pulse pressure augmentation, and reflection magnitude
RM]) and construct appropriate survival models and risk
eclassification indices to determine whether central aortic
ave reflections are an important risk factor for future
ardiovascular events. The authors found that increased RM
as independently associated with all cardiovascular events,
ard cardiovascular events, and especially incident HF. In
ddition, although the augmentation index and pulse pres-
ure augmentation did not offer much additional risk strat-
fication, RM resulted in improved risk reclassification for
ardiovascular events above and beyond traditional risk
actors. Provocatively, the authors also found that elevated
M in the absence of hypertension resulted in a similar
mount of risk for HF compared with hypertension with
ow RM.
How does increased RM lead to the development of HF?
lthough it is well known that increased late systolic load
i.e., increased RM) is associated with increased LV hyper-
rophy (11), even more important may be the myocardial
vents that coincide with the timing of the reflected wave in
ate systole. As shown by Chirinos et al. (12) in a prior study
n time-varying myocardial pressure–stress relationships,
V systolic wall stress—which has traditionally been mea-
ured only at end-systole—varies greatly during LV ejec-
ion. This finding is no surprise: the factors that determine
all stress (pressure, chamber radius, and wall thickness) all
ary dramatically during ejection. Chirinos et al. have
ioneered an elegant method for the determination of
nstantaneous measurement of wall stress using a combina-
ion of speckle-tracking echocardiography and arterial
onometry. Their prior study (12) showed that in healthy
ontrols and in hypertensive patients, peak systolic wall
tress occurs early during ejection, a protective feature, since
ave reflections from the systemic arterial circulation arrive
t the myocardium in late systole; thus cardiomyocytes are
rotected from increased late-systolic load. However, as
ypertension progresses, and as comorbidities such as cor-
http://dx.doi.org/10.1016/j.jacc.2012.07.055nary artery disease, obesity, and chronic kidney disease
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Figure 1 Proposed Schema for the Progression From Systemic Hypertension to Maladaptive Ventricular–Arterial Interaction to HF
The diagram compares 2 hypothetical patients, a 65-year-old woman with hypertension but no other cardiovascular risk factors (left panel; no heart failure) and a 65-year-old
woman with hypertension and multiple cardiovascular risk factors (right panel) who ultimately develops new-onset heart failure (HF). (A) Central aortic pressure profiles. Hyper-
tension and other cardiovascular risk factors (i.e., Stage A heart failure) contribute to abnormal systemic arterial structure and function, and lead to the development of abnor-
mal central aortic pressure profiles. The magnitude of the summed arterial reflected wave (i.e., reflection magnitude [RM]  ratio of backward pressure [Pb] to forward pressure
[Pf]) becomes progressively larger and leads to increased afterload in late systole. (B) Instantaneous myocardial wall stress during left ventricular ejection. The same cardiovas-
cular risk factors (including hypertension) that result in abnormal arterial structure and function also result in an increase in the magnitude and time-to-peak myocardial wall
stress during left ventricular ejection. This abnormal ventricular–arterial coupling represents a form of Stage B (asymptomatic) heart failure. (C) Confocal microscopy showing
myocyte T-tubule structure. The increased afterload in late systole due to the increased reflection magnitude, coupled with the delayed time-to-peak wall stress (with higher val-
ues of wall stress in late systole), causes increased tension on cardiomyocytes, leading to T-tubule disruption and disorganization (white arrows; compare these T-tubules to the
normal T-tubules in the left panel [yellow arrow]). (D) Longitudinal myocardial mechanics. T-tubule disruption leads to abnormal calcium handling in the myocyte, thereby result-
ing in cellular and whole-heart abnormalities in contractility and relaxation, such as reduced global longitudinal strain, which leads to further abnormalities in ventricular–arterial
coupling (i.e., myocardial pressure–stress relationships). Ultimately, these abnormalities lead to overt cardiac dysfunction, resulting in symptomatic, Stage C heart failure.
CAD  coronary artery disease; CKD  chronic kidney disease; T-tubule  transverse tubule.
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wall stress will likely occur later in ejection. This creates
increased cardiomyocyte vulnerability at a time when the
wave reflections from the systemic arterial circulation are
adding increased load (i.e., elevated RM).
Increased load on cardiomyocytes directly affects their
cellular structure and function. Transverse tubules (T-
tubules), which are essential for the spatial alignment
between L-type calcium channels and the sarcoplasmic
reticulum (13), become disorganized and disrupted early in
response to increased afterload (14). Disrupted T-tubules
lead to inefficient calcium cycling, which results in both
systolic and diastolic cardiomyocyte and whole-heart dys-
function (15). These abnormalities in cardiac function,
coupled with abnormal arterial function, ultimately lead to
symptomatic, Stage C HF (Fig. 1).
The study by Chirinos et al. (10) has several strengths,
including the large multiethnic cohort and the risk reclas-
sification statistical methods used to show the additive
benefit of measuring RM to predict future cardiovascular
risk. Although prior epidemiologic studies have investigated
other markers of arterial stiffness, such as carotid–femoral
pulse wave velocity (16), the study by Chirinos et al. (10) is
the first to use wave separation analysis for the calculation of
RM in a large epidemiological cohort study. Limitations of
the study include the use of a physiological flow waveform
instead of direct measurement of flow. Although prior
studies have validated the pressure-only approach of using
physiological flow waveforms to calculate RM (17), future
studies of the relationship between RM and HF will benefit
from measurement of proximal aortic flow using Doppler
echocardiography or phase-contrast magnetic resonance
imaging (18). As noted by the authors themselves in an
excellent tutorial on the noninvasive evaluation of LV
afterload (18,19), the use of radial arterial tonometry rep-
resents an additional limitation to their study. Carotid artery
tonometry, although technically more demanding, is pref-
erable when estimating central aortic pressure profiles.
Finally, due to the relatively low number of HF events
(though higher than other epidemiological studies [16]), the
authors could not determine whether their findings differed
by sex or race/ethnicity.
Given the findings by Chirinos et al. (10), the future is
bright for further investigation of central aortic pressure
characteristics, myocardial–arterial coupling, and HF. Sub-
sequent studies should explore further the relationship
between RM and time-varying myocardial pressure–stress
relationships in patients with and without HF (including
differences between HF with preserved EF and HF with
reduced EF), in relation to various HF risk factors, such as
coronary artery disease, chronic kidney disease, diabetes,
and obesity (along with sex and race/ethnic differences). In
epidemiological studies like MESA, further adjustment for
abnormal cardiac structure and function should help im-
prove our understanding of how increased RM leads to HF,
and serial measurements of arterial and ventricular struc-ture/function will permit better understanding of the
time course of abnormalities in myocardial–arterial cou-
pling in relation to HF development in the general
population.
Finally, existing and novel cardiovascular therapeutics
may reduce the magnitude of wave reflections and subse-
quently prevent the development of HF; therefore, incor-
poration of RM into clinical trials should be considered.
Given the finding in MESA that elevated RM in the
absence of hypertension conferred a similar risk as hyper-
tension with low RM, future clinical trials may benefit from
including elevated RM as an inclusion criteria (regardless of
the presence of hypertension). Alternatively, within a clin-
ical trial in hypertensive patients, an a priori subgroup
analysis stratified by high and low RM may provide further
insight into the utility of a given therapy on reducing RM as
a way to prevent HF.
In conclusion, Chirinos et al. (10) found that exaggerated
central aortic wave reflection, particularly increased RM, is
independently associated with incident cardiovascular
events and HF in a multiethnic cohort free of clinically
apparent cardiovascular disease. Elevated RM may represent
a novel form of Stage B HF, an intermediate step between
HF risk factors (i.e., Stage A HF) and overt, symptomatic
(Stage C) HF.
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